최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Prostaglandins & other lipid mediators, v.121 pt.A, 2015년, pp.131 - 137
Ostermann, A.I. , Herbers, J. , Willenberg, I. , Chen, R. , Hwang, S.H. , Greite, R. , Morisseau, C. , Gueler, F. , Hammock, B.D. , Schebb, N.H.
Epoxides from polyunsaturated fatty acids (PUFAs) are potent lipid mediators. In vivo stabilization of these epoxides by blockade of the soluble epoxide hydrolase (sEH) leads to anti-inflammatory, analgesic and normotensive effects. Therefore, sEH inhibitors (sEHi) are a promising new class of drugs...
J. Lipid Res. Buczynski 50 6 1015 2009 10.1194/jlr.R900004-JLR200 Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology
Kidney Int. Hoff 79 1 57 2011 10.1038/ki.2010.377 Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury
Pharmacol. Rep. Arnold 62 3 536 2010 10.1016/S1734-1140(10)70311-X Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids
Annu. Rev. Pharmacol. Morisseau 53 37 2013 10.1146/annurev-pharmtox-011112-140244 Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health
Int. J. Vasc. Med. Thomson 2012 605101 2012 Anti-inflammatory effects of epoxyeicosatrienoic acids
Prostaglandins Other Lipid Mediat. Wagner 96 1-4 76 2011 10.1016/j.prostaglandins.2011.08.001 Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception
Pharmacol. Rev. Fleming 66 4 1106 2014 10.1124/pr.113.007781 The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease
J. Pharmacol. Exp. Ther. Fang 314 1 260 2005 10.1124/jpet.105.085605 Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors
Am. J. Physiol. Heart Circ. Physiol. Larsen 290 2 H491 2006 10.1152/ajpheart.00927.2005 Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition
Science Node 285 5431 1276 1999 10.1126/science.285.5431.1276 Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
J. Lipid Res. Morisseau 51 12 3481 2010 10.1194/jlr.M006007 Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids
J. Clin. Invest. Panigrahy 122 1 178 2012 10.1172/JCI58128 Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Proc. Natl. Acad. Sci. U. S. A. Zhang 110 16 6530 2013 10.1073/pnas.1304321110 Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis
FASEB J. Kubota 28 2 586 2014 10.1096/fj.13-236224 Eicosapentaenoic acid is converted via omega-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid
J. Pharmacol. Exp. Ther. Snider 321 2 590 2007 10.1124/jpet.107.119321 Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides
Annu. Rev. Pharmacol. Toxicol. Morisseau 45 311 2005 10.1146/annurev.pharmtox.45.120403.095920 Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles
J. Med. Chem. Rose 53 19 7067 2010 10.1021/jm100691c 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain
Br. J. Pharmacol. Ulu 165 5 1401 2012 10.1111/j.1476-5381.2011.01641.x Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys
Eur. J. Pharm. Sci. Liu 48 4-5 619 2013 10.1016/j.ejps.2012.12.013 Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models
J. Cardiovasc. Pharmacol. Ulu 62 3 285 2013 10.1097/FJC.0b013e318298e460 Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension
J. Cardiovasc. Pharmacol. Ulu 64 1 87 2014 10.1097/FJC.0000000000000094 An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension
Proc. Natl. Acad. Sci. U. S. A. Sirish 110 14 5618 2013 10.1073/pnas.1221972110 Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis
Cell Biol. Toxicol. Meredith 4 4 405 1988 10.1007/BF00117769 Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture
Food Chem. Willenberg 166 537 2015 10.1016/j.foodchem.2014.06.038 Development of an online-SPE-LC-MS method for the investigation of the intestinal absorption of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PHIP) and its bacterial metabolite PHIP-M1 in a Caco-2 Transwell system
Food Chem. Willenberg 167 245 2015 10.1016/j.foodchem.2014.06.103 Investigation of the absorption of resveratrol oligomers in the Caco-2 cellular model of intestinal absorption
Biochem. Biophys. Res. Commun. Artursson 175 3 880 1991 10.1016/0006-291X(91)91647-U Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
Pharm. Res. Rubas 10 1 113 1993 10.1023/A:1018937416447 Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption
Anal. Methods Schebb 3 2 420 2011 10.1039/C0AY00714E Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies
Prostaglandins Other Lipid Mediat. Gomolka 94 3-4 81 2011 10.1016/j.prostaglandins.2010.12.006 Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples
Toxicol. Lett. Nicken 196 1 60 2010 10.1016/j.toxlet.2010.04.002 Uptake of the colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different segments of the rat gastrointestinal tract: its implication in colorectal carcinogenesis
Anal. Bioanal. Chem. Ostermann 407 5 1403 2015 10.1007/s00216-014-8377-4 Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS/MS
Anal. Bioanal. Chem. Schebb 400 5 1359 2011 10.1007/s00216-011-4861-2 Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors
Proc. Natl. Acad. Sci. U. S. A. Inceoglu 108 12 5093 2011 10.1073/pnas.1101073108 Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP
Proc. Natl. Acad. Sci. U. S. A. Inceoglu 109 28 11390 2012 10.1073/pnas.1208708109 Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes
Adv. Drug Deliv. Rev. Lipinski 46 1-3 3 2001 10.1016/S0169-409X(00)00129-0 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Pharmacol. Res. Sasso 97 7 2015 10.1016/j.phrs.2015.04.001 Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive
J. Pharm. Sci. Gibaldi 60 9 1338 1971 10.1002/jps.2600600909 Influence of first-pass effect on availability of drugs on oral administration
Drug Metab. Dispos. Schebb 40 1 25 2012 10.1124/dmd.111.042283 In vitro glucuronidation of the antibacterial triclocarban and its oxidative metabolites
J. Cardiovasc. Pharmacol. Ulu 2013 10.1097/FJC.0b013e318298e460 Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II dependent hypertension
Chemosphere Schebb 87 7 825 2012 10.1016/j.chemosphere.2011.12.077 Whole blood is the sample matrix of choice for monitoring systemic triclocarban levels
J. Biol. Chem. Wu 271 7 3460 1996 10.1074/jbc.271.7.3460 Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart
Biochem. Pharmacol. Gill 29 3 389 1980 10.1016/0006-2952(80)90518-3 Distribution and properties of a mammalian soluble epoxide hydrase
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.